Back to mobile site

Apogee Therapeutics Inc (APGE) PT Lowered to $81 at Truist Securities

May 27, 2026 12:39 PM EDT Send to a Friend
Truist Securities analyst Danielle Brill lowered the price target on Apogee Therapeutics Inc (NASDAQ: APGE) to $81.00 (from $83.00) while ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login